Mycobacterium Citations List: December 2023

Literature Citations

1. Synthesis, Docking and in Vitro Evaluation of Spiroindoline-3,2'-quinazoline Derivatives. Addu, N., H. Miriyala, R. Kapavarapu, S.K. Kolli, and M. Pal. ChemistrySelect, 2023. 8(45): e202302793. ISI[001111657300001].
[WOS]. TB_12_2023.

2. Contezolid Can Replace Linezolid in a Novel Combination with Bedaquiline and Pretomanid in a Murine Model of Tuberculosis. Almeida, D., S.Y. Li, J. Lee, B. Hafkin, K. Mdluli, N. Fotouhi, and E.L. Nuermberger. Antimicrobial Agents and Chemotherapy, 2023. 67(12): e0078923. PMID[37966090]. PMCID[PMC10720489].
[PubMed]. TB_12_2023.

3. A Genome-wide Overexpression Screen Reveals Mycobacterium smegmatis Growth Inhibitors Encoded by Mycobacteriophage Hammy. Amaya, I., K. Edwards, B.M. Wise, A. Bhattacharyya, C.H.D. Pablo, E. Mushrush, A.N. Coats, S. Dao, G. Dittmar, T. Gore, T.M. Jarva, G. Kenkebashvili, S. Rathan-Kumar, G.M. Reyes, G.L. Watts, V.K. Watts, D. Dubrow, G. Lewis, B.H. Stone, B. Xue, S.G. Cresawn, D. Mavrodi, V. Sivanathan, and D. Heller. G3: Genes, Genomes, Genetics, 2023. 13(12): jkad240. PMID[37934806]. PMCID[PMC10700055].
[PubMed]. TB_12_2023.

4. In Silico Virtual Screening for the Identification of Novel Inhibitors against Dihydrodipicolinate reductase (DapB) of Mycobacterium tuberculosis, A Key Enzyme of Diaminopimelate Pathway. Angrish, N., N. Lalwani, and G. Khare. Microbiology Spectrum, 2023. 11(6): e0135923. PMID[37855602]. PMCID[PMC10714930].
[PubMed]. TB_12_2023.

5. Norfloxacin Derivatives as DNA Gyrase and Urease Inhibitors: Synthesis, Biological Evaluation and Molecular Docking. Awan, B., M.A. Khan, I. Ahmad, A. Masood, A. Raza, S. Khaliq, F. Ullah, J. Ahmed, and M.R. Khan. Future Medicinal Chemistry, 2023. 15(23): p. 2181-2194. PMID[37997685].
[PubMed]. TB_12_2023.

6. Design, Synthesis and Antitubercular Assessment of 1,2,3-Triazole Incorporated Thiazolylcarboxylate Derivatives. Bakale, R.D., S.M. Sulakhe, S.L. Kasare, B.P. Sathe, S.S. Rathod, P.B. Choudhari, E. Madhu Rekha, D. Sriram, and K.P. Haval. Bioorganic & Medicinal Chemistry Letters, 2024. 97: 129551. PMID[37979730].
[PubMed]. TB_12_2023.

7. In Vitro Antimycobacterial Activity and Interaction Profiles of Diarylthiourea-copper (II) Complexes with Antitubercular Drugs against Mycobacterium tuberculosis Isolates. Bielenica, A., A. Głogowska, E. Augustynowicz-Kopeć, J. Orzelska-Górka, D. Kurpios-Piec, and M. Struga. Tuberculosis, 2023. 143: 102412. PMID[37774599].
[PubMed]. TB_12_2023.

8. Synthesis of 1,3,4-Oxadiazoles with 4-Methoxynaphthalene Ring: Discovering New Compounds with Antimicrobial Activity. Frederico Rozada, A.M., F.A. Vilugron Rodrigues-Vendramini, E.S. Kioshima, E.G. Sampiron, R.B. de Lima Scodro, K.R. Caleffi-Ferracioli, F.A. Vicente Seixas, E.A. Basso, and G. Freitas Gauze. Future Medicinal Chemistry, 2023. 15(24): p. 2239-2255.PMID[38014535].
[PubMed]. TB_12_2023.

9. Regioselective and Stereoselective Synthesis of Parthenolide Analogs by Acyl Nitroso-ene Reaction and Their Biological Evaluation against Mycobacterium tuberculosis. Gioia, B., F. Ruggieri, A. Biela, V. Landry, P. Roussel, C. Piveteau, F. Leroux, R.C. Hartkoorn, and N. Willand. International Journal of Molecular Sciences, 2023. 24(24): 17395. PMID[38139224]. PMCID[PMC10744032].
[PubMed]. TB_12_2023.

10. Repurposing Azoles to Resolve Serotogenic Toxicity Associated with Linezolid to Combat Multidrug-resistant Tuberculosis. Girase, R.T., I. Ahmad, J.M. Oh, H. Kim, B. Mathew, S.K. Vagolu, T. Tønjum, N.C. Desai, D. Sriram, J. Kumari, and H.M. Patel. ACS Medicinal Chemistry Letters, 2023. 14(12): p. 1754-1759. PMID[38116435]. PMCID[PMC10726462].
[PubMed]. TB_12_2023.

11. Bedaquiline, Delamanid, Linezolid, Clofazimine, and Capreomycin MIC Distributions for Drug Resistance Mycobacterium tuberculosis in Shanghai, China. Guo, Y., J. Yang, W. Wang, X. Wu, B. Wan, H. Wang, W. Sha, and F. Yu. Infection and Drug Resistance, 2023. 16: p. 7587-7595. PMID[38107433]. PMCID[PMC10723587].
[PubMed]. TB_12_2023.

12. Whole Cell Hydride Meisenheimer Complex Biotransformation Guided Optimization of Antimycobacterial Benzothiazinones. Joch, M., K.P. Wojtas, H. Torres-Gómez, Y. Li, F. Meyer, M. Straßburger, V. Kerndl, H.M. Dahse, C. Hertweck, H. Hoffmann, H. Görls, K. Walter, C. Hölscher, and F. Kloss. European Journal of Medicinal Chemistry, 2024. 264: 116023. PMID[38071794].
[PubMed]. TB_12_2023.

13. Phenolic Substitution in Fidaxomicin: A Semisynthetic Approach to Antibiotic Activity Across Species. Jung, E., A. Kraimps, S. Dittmann, T. Griesser, J. Costafrolaz, Y. Mattenberger, S. Jurt, P.H. Viollier, P. Sander, S. Sievers, and K. Gademann. ChemBioChem, 2023. 24(24): e202300570. PMID[37728121].
[PubMed]. TB_12_2023.

14. N4-Substituted piperazinyl norfloxacin Derivatives with Broad-spectrum Activity and Multiple Mechanisms on Gyrase, Topoisomerase IV, and Bacterial Cell Wall Synthesis. Kamal El-Sagheir, A.M., I. Abdelmesseh Nekhala, M.K. Abd El-Gaber, A.S. Aboraia, J. Persson, A.B. Schäfer, M. Wenzel, and F.A. Omar. ACS Bio & Med Chem Au, 2023. 3(6): p. 494-506. PMID[38144255]. PMCID[PMC10739246].
[PubMed]. TB_12_2023.

15. Exploring the Antimicrobial Potential of Isoniazid Loaded Cu-based Metal-organic Frameworks as a Novel Strategy for Effective Killing of Mycobacterium tuberculosis. Kumar, P., A. Behera, P. Tiwari, S. Karthik, M. Biswas, A. Sonawane, and S.M. Mobin. Journal of Materials Chemistry B, 2023. 11(45): p. 10929-10940. PMID[37937634].
[PubMed]. TB_12_2023.

16. New Application of Cyclo Saligenyl Prodrugs Approach for the Delivery of Fosfoxacin Derivatives in Mycobacteria. Munier, M., D. Tritsch, D. Lièvremont, M. Rohmer, and C. Grosdemange-Billiard. Molecules, 2023. 28(23): 7713. PMID[38067444]. PMCID[PMC10707747].
[PubMed]. TB_12_2023.

17. Anti-tuberculosis Potential of OJT008 against Active and Multi-drug-resistant Mycobacterium tuberculosis: In Silico and in Vitro Inhibition of Methionine aminopeptidase. Onyenaka, C., K.A. Idowu, N.P. Ha, E.A. Graviss, and O.A. Olaleye. International Journal of Molecular Sciences, 2023. 24(24): 17142. PMID[38138972]. PMCID[PMC10742973].
[PubMed]. TB_12_2023.

18. Evaluating Amikacin Minimum Inhibitory Concentration in Trailing Growth for Mycobacterium avium Complex. Park, B., T.S. Shim, K.W. Jo, E.J. Won, M.N. Kim, and H. Sung. Tuberculosis, 2023. 143: 102427. PMID[37918057].
[PubMed]. TB_12_2023.

19. GaMF1.39's Antibiotic Efficacy and its Enhanced Antitubercular Activity in Combination with Clofazimine, Telacebec, ND-011992, or TBAJ-876. Ragunathan, P., P. Shuyi Ng, S. Singh, W.H. Poh, D. Litty, N.P. Kalia, S. Larsson, A. Harikishore, S.A. Rice, P.W. Ingham, V. Müller, G. Moraski, M.J. Miller, T. Dick, K. Pethe, and G. Grüber. Microbiology Spectrum, 2023. 11(6): e0228223. PMID[37982630]. PMCID[PMC10715162].
[PubMed]. TB_12_2023.

20. Rationally Designed Novel Phenyloxazoline synthase Inhibitors: Chemical Synthesis and Biological Evaluation to Accelerate the Discovery of New Antimycobacterial Antibiotics. Shyam, M., G. Bhattacharje, C. Daniel, A. Kumar, P. Yadav, P. Mukherjee, S. Singh, A.K. Das, T. Narender, A. Singh, V. Jayaprakash, and S. Bhakta. Molecules, 2023. 28(24): 8115. PMID[38138601]. PMCID[PMC10745776].
[PubMed]. TB_12_2023.

21. Synthesis, Antimycobacterial Evaluation, and Molecular Docking Study of 1,2,4-Triazole Derivatives. Xia, M.Y., Y.X. Cai, J.X. Chen, X. Zhao, H.M. Dong, and Z.C. Yang. Journal of Enzyme Inhibition and Medicinal Chemistry, 2023. 38(1): 2229070. PMID[37381729]. PMCID[PMC10312031].
[PubMed]. TB_12_2023.

22. Design, Synthesis, In Vitro and In Silico Evaluation of Novel Substituted 1,2,4-Triazole Analogues as Dual Human VEGFR-2 and TB-InhA Inhibitors. Zawal, A.G., M.M. Abdel-Aziz, M.H. Elbatreek, A.A. El-Shanawani, L.M. Abdel-Aziz, and S.S. Elbaramawi. Bioorganic Chemistry, 2023. 141: 106883. PMID[37774433].
[PubMed]. TB_12_2023.

23. Discovery of Novel and Potent InhA Direct Inhibitors by Ensemble Docking-based Virtual Screening and Biological Assays. Zhang, Q., J. Han, Y. Zhu, F. Yu, X. Hu, H.H.Y. Tong, and H. Liu. Journal of Computer-Aided Molecular Design, 2023. 37(12): p. 695-706. PMID[37642861].
[PubMed]. TB_12_2023.

Patent Citations

24. Preparation of Novel Albicidin Derivatives as Antibacterial Agents. Suessmuth, R., J. Weston, L. Kleebauer, L. Zborovsky, and K. Hommernick. Patent. 2023. WO2023-EP63580 2023232519: 32pp.
[Patent]. TB_12_2023.

25. Penem Antibacterials against Mycobacterial Pathogens and D,D- and L,D Transpeptidases. Townsend, C.A. and H.R. Bachelder. Patent. 2023. WO2023-US24103 2023235456: 70pp.
[Patent]. TB_12_2023.

26.Ethyl 2-Substituted-1-(substituted-benzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate Derivatives as Anti-tubercular Agents. Venugopala, K.N., P.K. Deb, M. Pillay, S. Chandrashekharappa, M.A. Morsy, B. Aldhubiab, M. Attimarad, A.B. Nair, N. Sreeharsha, C. Tratrat, S. Shashikanth, V. Uppar, and B. Padmashali. Patent. 2023. US2023-237211 11845746: 13pp.
[Patent]. TB_12_2023.

27. Preparation of Tricyclic Spirolactam Compounds with Antimycobacterial Activity. Willand, N., T. Abdesselam-Hattabi, R.C. Hartkoorn, B. Deprez, B. Villemagne, S. Tangara, S. Dam, M. Flipo, and L. Faieon. Patent. 2023. WO2023-EP65174 2023237580: 171pp.
[Patent]. TB_12_2023.